HEALTHglobal
[Correspondence] Respiratory virus research needs its own PPIE
Single source
Updated 2 hours ago
First seen March 20, 2026 10:59:50Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Patient perspectives are essential alongside clinical and economic evidence in health-care decision making, yet reporting of patient and participant involvement (PPI) in randomised controlled trials remains poor.1 After the COVID-19 pandemic, respiratory virus research in some countries has been deprioritised, with a sense that the public has “already lived through” the pandemic and there is little left to discuss.2,3